Document and Entity Information Liquidated Damages and Other Forbearance Costs This item represents expenses related to liquidated damages and other forbearance costs incurred by the entity during the reporting period. Liquidated damages and other forbearance agreement settlement costs Preferred Stock Beneficial Conversion Feature Accreted as Dividend Dividend accreted due to a favorable spread to a preferred stock holder between the amount of preferred stock being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible preferred stock issued that is in-the-money at the commitment date. Series A Preferred beneficial conversion feature accreted as a dividend Series A Convertible Preferred stock conversion rate change accreted as a dividend Adjustment to Additional Paid in Capital for Waiver of Founder Deferred Compensation Waiver of founders' deferred compensation Increase to additional paid in capital for deferred compensation waived during the reporting period. Issuance of common stock to founders for cash at $0.0012 per share Stock Issued During Period, Value, Founder Issues Equity impact of the value of stock issued to the founding stockholder during the period. Issuance of common stock to founders for cash at $0.0012 per share (in shares) Stock Issued During Period, Shares, Founder Issues Number of stocks issued to the founding stockholder during the period. Award Type [Axis] Capital contribution of cash Adjustment to Additional Paid in Capital for Capital Contribution by Stockholders Equity impact of the value of the capital contributed by shareholders to the entity during the reporting period. Share Exchange During Period with Founder Share exchange with founders Equity impact of the value of shares exchanged by the entity during the reporting period. Share Exchange During Period, Shares with Founder Share exchange with founders (in shares) Number of shares exchanged by the entity during the reporting period. Issuance of treasury shares to escrow Equity impact of the amount of treasury stock issued to escrow. Treasury Stock Issued to Escrow Value Amendment Description Issuance of treasury shares to escrow (in shares) Treasury Stock Issued to Escrow, Shares Number of treasury stock shares issued to escrow. Amendment Flag Stock and Warrants Issued During Period Value New Issues Issuance of common stock and warrants for cash at $6.00 and $11.70 per share for the year ended January 31, 2007 and 2005, respectively The equity impact of the value of stock and warrants issued during the reporting period. Stock and Warrants Issued During Period Shares New Issues Issuance of common stock and warrants for cash (in shares) Number of shares and warrants issued during the reporting period. Private placement of common stock Stock and Warrants Issued During Period Value New Issues Other The equity impact of the value of other stock and warrants issued during the reporting period. Stock and Warrants Issued During Period Shares New Issues Other Number of other shares and warrants issued during the reporting period. Private placement of common stock (in shares) Preferred Stock and Warrants Issued During Period Value New Issues Private placement of preferred stock and warrants for cash at $10.00 per share (restated) The equity impact of the value of preferred stock and warrants issued during the reporting period. Preferred Stock and Warrants Issued During Period Shares New Issues Private placement of preferred stock and warrants for cash at $10.00 per share (restated) (in shares) Number of preferred shares and warrants issued during the reporting period. Stock Issued During Period Value Finder Fees Common stock issued to selling agents Stock issued for payment of finders fees. Stock Issued During Period Shares Finder Fees Common stock issued to selling agents (in shares) Number of stock issued for payment of finders fees. Adjustments to Additional Paid in Capital Warrant Issued Other Issuance of 17,572 warrants issued to selling agents Increase in additional paid in capital due to warrants issued during the period to selling agents. Issuance of 27,425 units to finder Adjustments to Additional Paid in Capital Units Issued Other Increase in additional paid in capital due to units issued during the period to selling agents. Amortization of deferred stock-based compensation Amortization of Deferred Stock Based Compensation Expense Amortization of deferred stock based compensation recognized related to stock options during the period. Options issued to consultants Adjustment to Additional Paid in Capital for Options Issued to Consultants Increase in additional paid in capital due to options issued for services during the reporting period. Adjustment to Additional Paid in Capital for Warrants Issued to Consultants Warrants issued to consultants Increase in additional paid in capital due to warrants issued for services during the reporting period. Return of treasury shares from escrow Return of Treasury Stock from Escrow During Period Value Equity impact of the value of treasury stock returned from escrow. Return of Treasury Stock from Escrow, Shares Return of treasury shares from escrow (in shares) Number of treasury shares returned from escrow. Conversion of Series A preferred stock and issuance of common stock (in shares) Convertible Preferred Stock Shares Converted to Other Securities Number of shares of convertible preferred stock that was converted to other securities. Current Fiscal Year End Date Reclassification of Deferred Unamortized Stock Based Compensation Implementation of ASC 718 Adjustment to additional paid-in capital resulting from the reclassification of deferred unamortized stock-based compensation upon adoption of FAS 123R during the period. Adjustment to Additional Paid in Capital for Value Attributed to Warrants Value attributed to warrants issued with 6% convertible debentures Increase in additional paid in capital due to warrants issued during the period in relation to convertible debt. Adjustment to Temporary Equity for Finders Fees and Expenses Direct costs associated with issuing stock that is deducted from temporary equity and is paid in cash. Payment of selling agents fees and expenses in cash Stock Issued During Period, Value Convertible Debenture Forbearance Agreement The net amount of stock issued during the period in accordance with a convertible debenture forbearance agreement. Issuance of shares of common stock in payment of convertible debenture interest in accordance with Forbearance Agreement Stock Issued During Period, Shares Convertible Debenture Forbearance Agreement The number of shares of stock issued during the period in accordance with a convertible debenture forbearance agreement. Issuance of shares of common stock in payment of convertible debenture interest in accordance with forbearance agreement (in shares) The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments. Stock Issued During Period Value Conversion of Convertible Securities Net of Adjustments Other Conversion of debenture to common stock Stock Issued During Period Shares Conversion of Convertible Securities Net of Adjustments Other Conversion of debenture to common stock (in shares) Number of shares issued during the period upon the conversion of convertible securities, net of adjustments. Adjustment to Additional Paid in Capital for Finders Fees and Expenses One Payment of selling agents fees and expenses in cash Finders and selling agents fees associated with issuing stock that is deducted from additional paid in capital and is paid in cash. Adjustment to Additional Paid in Capital for Finders Fees and Expenses Two Payment of selling agents fees and expenses in cash Finders fees and expenses associated with issuing stock that is deducted from additional paid in capital and is paid in cash. Adjustment to Additional Paid in Capital for Warrants Issued to Selling Agents Issuance of warrants to selling agents The value of adjustments to additional paid in capital for warrants issued to selling agents. Finders warrants charged to cost of capital Warrants issued for finders and selling agent fess associated with issuing stock that is deducted from additional paid in capital. Adjustments to Additional Paid in Capital Warrant Charged Document Period End Date Adjustment to Additional Paid in Capital for Finders Fees and Expenses Preferred Stock Selling agents warrants charged to cost of capital Warrants issued for direct costs associated with issuing stock that is deducted from additional paid in capital. Reclassification of common stock initially recorded as temporary equity Stock Issued During Period Value Reclassification of Temporary Equity The equity impact of stock issued due to reclassification of temporary equity to common stock. Reclassification of common stock initially recorded as temporary equity (in shares) Stock Issued During Period Shares Reclassification of Temporary Equity Number of shares issued due to reclassification of temporary equity to common stock. Reclassification of Derivative Financial Instruments Correction of error in derivative liability - fair value of warrants price protected units issued Adjustment to equity resulting from the reclassification of derivative financial instruments due to correction of an error. Correction of error in derivative financial instruments Correction of error in derivative financial instruments Private placement of common stock or units Common Stock Issued During Period Value Private Placement Equity impact of the value of new stock issued during the period via private placement. Private placement of common stock or units (in shares) Common Stock Issued During Period Shares Private Placement Number of common stock shares issued during the period via private placement. Adjustments to Additional Paid in Capital, Warrants Price Protected Units Value The fair value of warrants and price protected units determined upon issuance. Derivative liability-fair value of warrants and price protected units issued Fair value of new warrants issued during the period Adjustments to Additional Paid in Capital Warrants Reclassified Amount Fair Value of Warrants Reclassified to Additional Paid in Capital Reclassification of derivative financial instruments to additional paid in capital This element represent adjustments to additional paid in capital due to reclassification of warrants. Warrants classified to Additional Paid in Capital Reclassification of derivative financial instruments to additional paid in capital Stock Issued During Period Value Selling Agents Issuance of common stock to selling agents Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock to selling agents. Entity [Domain] Stock Issued During Period Shares Selling Agents Issuance of common stock to selling agents (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock to selling agents. Stock Issued During Period, Value Non Exclusive Selling Agent Agreement Value of stock issued pursuant to a non-exclusive selling agent's agreement. Issuance of common stock in connection with consulting services Stock Issued During Period, Shares Non Exclusive Selling Agent Agreement Number of shares issued pursuant to a non-exclusive selling agent's agreement. Issuance of common stock in connection with consulting services (in shares) Stock Issued During Period, Value Consulting Services Rendered The net amount of stock issued during the period for the settlement of consulting services rendered. Issuance of shares of common stock re settlement for consulting services rendered Stock Issued During Period, Shares Consulting Services Rendered Number of shares issued during the period as a result of the settlement of consulting services rendered. Issuance of shares of common stock re settlement for consulting services rendered (in shares) Shares issued in settlement of legal fees Stock Issued During Period Value for Legal Fees Represents the value of stock issued for legal fees by the entity during the reporting period. Shares issued in settlement of legal fees (in shares) Stock Issued During Period Shares for Legal Fees Number of shares issued during the period in settlement of legal fees. Stock Issued During Period Value Severance Stock issued in payment of deferred salary to former CEO The value of stock issued by the entity during the reporting period relating to severance agreements. Stock Issued During Period, Shares Severance Stock issued in payment of deferred salary to former CEO (in shares) Number of shares issued during the reporting period relating to severance agreements. Consulting services settled via issuance of stock Stock Issued During Period Value Consulting Agreement The net amount of stock issued during the period for consulting. Consulting services settled via issuance of stock (in shares) Stock Issued During Period Shares Consulting Agreement Number of shares issued during the period for consulting. Adjustment to Additional Paid in Capital for Donated Services Donated services Increase in additional paid in capital due to donated services. Stock issued in connection with conversion of convertible debentures Stock Issued During Period Value Conversion of Convertible Securities Second The net amount of stock issued during the period for convertible debenture interest in accordance with a convertible debenture agreement second. Stock issued in connection with conversion of convertible debentures (in shares) Stock Issued During Period Shares Conversion of Convertible Securities Second Number of shares issued during the period for convertible debenture interest in accordance with a convertible debenture agreement second. Stock Issued During Period Value Accrued Consulting Agreement Accrued Liability-SBCE at 12/31/09-Consulting agreement Value of stock issued for consulting. Stock Issued During Period Shares Accrued Consulting Agreement Number of stocks issued for consulting. Accrued Liability-SBCE at 12/31/09-Consulting agreement (in shares) Warrants issued to lead investor in connection with 6% convertible debentures as compensation Adjustment to Additional Paid in Capital to Lead Investors of Debentures Increase in additional paid in capital due to warrants issued for services during the period in relation to convertible debt. Adjustments to Additional Paid in Capital Share Based Compensation Non Employees Requisite Service Period Recognition Value Stock-based compensation expense for non-employees Represents the amount of recognized equity-based compensation during the period to non-employees. Accretion of convertible note discount Adjustment to Additional Paid in Capital for Accretion of Convertible Note Discount Increase in additional paid in capital due to the accretion of convertible note discounts during the reporting period. Warrants issued to lead investor in connection with November 2006 put transaction as compensation Adjustment to Additional Paid in Capital to Lead Investors of Put Transaction Increase in additional paid in capital due to warrants issued during the period for services in relation to put transactions. Adjustment to Additional Paid in Capital for Share Issued for Donated Services Fair value of donated services CEO Represents the fair value of adjustments to additional paid in capital for donated services by management. Temporary Equity-Unregistered Common Stock Temporary Equity Unregistered Common Stock [Member] Temporary equity unregistered common stock is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Issuance of Common Stock to Founders for Cash Per Share Issuance of common stock to founders for cash Represents the value per share for stock issued to founders for cash during the reporting period. Issuance of Common Stock for Cash Per Share Issuance of common stock for cash Represents the value per share for stock issued for cash during the reporting period. Issuance of Common Stock and Warrants for Cash Per Share Issuance of common stock and warrants for cash Represents the value per share for common stock and warrants issued for cash during the reporting period. Issuance of warrants to selling agents (in shares) Represents the number of shares issued to selling agents during the reporting period. Issuance of Warrants to Selling Agents Share Issuance of Warrants to Selling Agents Share Other Issuance of warrants to selling agents (in shares) Represents the number of shares issued to other selling agents during the reporting period. Issuance of units to finder (in shares) Issuance of Units to Finders Share Other Represents the number of units issued to other finders during the reporting period. Issuance of Preferred Stock and Warrants for Cash Per Share Issuance of preferred stock and warrants for cash Represents the value per share for preferred stock and warrants issued for cash during the reporting period. Issuance of Common Stock and Warrants Other for Cash Per Share Issuance of common stock and warrants for cash Represents the value per share for other common stock and warrants issued for cash during the reporting period. Founders' compensation contributed to equity Founders Compensation Contributed to Equity Represents the value of founders' compensation expenses contributed to equity during the reporting period. Donated services contributed to equity Donated Services Contributed to Equity Represents the value of donated services expenses contributed to equity during the reporting period. Settlement of consulting services in stock Settlement of Consulting Services in Stock The noncash adjustment for the settlement of consulting services in stock during the reporting period of the entity. Represents the stock based expense incurred by the entity for liquidated damages and other forbearance agreement settlement costs during the reporting period. Stock Based Liquidated Damages and Forbearance Settlement Costs Liquidated damages and other forbearance agreement settlement costs paid in stock Stock Based Expense for Severance Pay Stock issued in connection with payment of deferred salary Represents the stock based expense incurred by the entity for severance of employees during the reporting period. Stock issued in connection with settlement of legal fees Stock Based Expense for Legal Fees Represents the value of stock-based expense for settlement of legal fees during the reporting period. Stock Based Expense for Consulting Services Stock and warrant issued in connection with consulting services Represents the stock based expense incurred by the entity for consulting services during the reporting period. Proceeds from a non-exclusive selling agent's agreement Proceeds from Non Exclusive Selling Agent Agreement The cash inflow from amounts received from a non-exclusive selling agent's agreement. Costs associated with recapitalization Payment for Recapitalization Cost Represents the cash outflow due to recapitalization cost during the reporting period. Conversion of Stock [Abstract] Conversion of 174,000 shares of preferred stock into 137,739 shares of common stock: Surrender of Preferred Stock Surrender of 174,000 shares of preferred stock Represents the value of preferred stock surrendered in non cash investing and financing activities during the reporting period. Stock Issued Two Issuance of 41,750 shares of common stock for Board of Directors' fees in lieu of cash payment The fair value of stock issued in noncash activities. Preferred stock dividends accrued Preferred Stock Dividend Accrued Represents the value of preferred stock dividend accrued during the reporting period. Summary of Significant Accounting Policies Interest paid on common stock Interest Paid on Common Stock This element Represent Interest Paid on Common Stock. Surrender of Preferred Stock, Shares Surrender shares of preferred stock Represents the number of preferred stock shares surrendered in non cash investing and financing activities during the reporting period. Entity Well-known Seasoned Issuer Common Stock Issued in Lieu of Cash Payment Shares Issuance of common stock for Board of Directors' fees in lieu of cash payment, shares This element represents shares issued during the period in lieu of cash payments to be made by reporting entity. Entity Voluntary Filers Equity Offering [Table] Table that contains information on stock issued under different types of offering. Entity Current Reporting Status Type of Offering [Axis] Pertinent information classified by type of offering. Entity Filer Category Type of Offering [Domain] Name of stock transaction which may include details of the offering, a description of the stock sold, percentage of stock sold, a description of the investors and whether the stock was issued in a business combination. Entity Public Float Components of Change [Domain] Represents the types of changes that can affect the valuation of an item in the financial statements. Entity Registrant Name Warrants Issued During Period [Member] Represents the security issued during the period that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Fair value of new warrants issued during the period Entity Central Index Key Public Offering [Member] Registered direct public offering Represents the public offering of shares of the entity. Equity Offering [Line Items] Common Stock Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Units Issued During Period New Issues Units issued (in shares) Number of units issued during the reporting period. Sale of Capital Unit Number of Common Shares in Each Unit Represents the number of shares of common stock included in each unit sold. Number of shares of common stock in each capital unit (in shares) Entity Common Stock, Shares Outstanding Represents the number of warrants that are included in each capital unit sold. Sale of Capital Unit Number of Warrants in Each Unit Number of common stock purchase warrants in each capital unit Amount of underwriting discounts and commissions Represents the amount of underwriting discounts and commissions incurred due to the issuance of equity. Equity Issuance Amount of Underwriting Discounts and Commissions Equity Issuance Amount of Offering Expenses Amount of offering expenses Represents the amount of offering expenses incurred due to the issuance of equity. Period from Date of Prospectus for Transferability of Common Stock and Warrants Period after which common stock and warrants can be separately transferred Represents the period from the date of the prospectus after which common stock and warrants can be separately transferred. Class of Warrant or Right Term of Warrants or Rights Term of warrants The period over which each class of warrants or rights outstanding may be exercised. Stockholders Equity Note Reverse Stock Split Conversion Ratio Reverse stock split conversion ratio Represents the conversion ratio used in the calculation of a reverse stock split. Going Concern [Abstract] Going Concern Period within which Additional Capital is Required to be Raised Period within which additional capital is to be raised Represents the period during which the reporting entity is required to raise additional capital to complete the development and commercialization of current product candidates and to continue to fund operations at its current cash expenditure levels. Share Based Compensation Shares Authorized under Stock Option Plans, Exercise Price Per Share Range [Abstract] Exercise Price Per Share Share Based Compensation, Arrangement by Share Based Payment Award, Options, Grants in Period Option Exercise Price Upper End of the Range Limit Represents the exercise price of shares granted during the period and outstanding under all stock option plans, upper end of the range limit. Exercise price, upper end of the range, for awards granted (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award, Options Grants in Period Option, Exercise Price, Lower Range Limit Represents the exercise price of awards granted during the period and outstanding under all stock option plans, lower end of the range limit. Exercise price, low end of the range, for awards granted (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award Options Forfeitures in Period Option Exercise Price Forfeited (in dollars per share) Represents the exercise price per option at which grantees could have acquired the underlying shares with respect to stock options that were terminated during the reporting period due to noncompliance with plan terms during the reporting period. Share Based Compensation Arrangement by Share Based Payment Award, Options Exercisable in Period Option, Exercise Price, Upper Range Limit Represents the exercise price of awards exercisable during the period and outstanding under all stock option plans, upper end of the range limit. Exercise price, upper end of the range, for awards exercisable (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award, Options Exercisable in Period Option, Exercise Price, Lower Range Limit Represents the exercise price of awards exercisable during the period and outstanding under all stock option plans, lower end of the range limit. Exercise price, low end of the range, for awards exercisable (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Intrinsic Value Granted The total accumulated difference between fair values of underlying shares on dates of grant and grant price on options which were granted (or share units converted) into shares during the reporting period under the plan. Share Based Compensation Arrangement by Share Based Payment Award Options Forfeitures in Period Intrinsic Value Forfeited The accumulated differences between the fair values of underlying shares and exercise prices to acquire such shares as of the grant date on options that were forfeited. Class of Warrant or Right Number of Warrants Issued Warrants issued Represents the number of each class of warrants or rights issued during the reporting period. Document Fiscal Year Focus Number of Private Placement Financings Number of private placement financings Represents the number of private placement financings through which the entity issued common stock and warrants. Document Fiscal Period Focus Proceeds from Issuance of Common Stock, Gross Gross proceeds Represents the gross proceeds from issuance of common stock before deducting the underwriting discounts, commissions and other offering expenses. Payment of Finders Fees Finder's fees paid Represents the amount of finder's fees paid during the period. Multi Gen Diagnostics Inc [Member] MultiGen Diagnostics, Inc. Represents the MultiGen Diagnostics, Inc., a company with which the entity entered into an asset purchase agreement. Schedule of Stockholders Equity [Table] Schedule detailing information related to shareholders' equity. Information pertaining to equity issuance to recipients. Equity Issuance by Recipients [Axis] Equity Issuance Recipients [Domain] Represents the name or title of the recipient, to whom the equity instrument has been issued. Selling Agents [Member] Selling agents Represents information pertaining to selling agents. Licensing Agreements SpaXen Joint Venture SpaXen Joint Venture Joint Venture Disclosure [Text Block] Represents entire disclosure of investment in joint venture. Basis of Presentation and Going Concern Disclosure [Abstract] Legal Entity [Axis] The entire disclosure for the basis of presentation, an entity's ability to continue as a going concern, and the effect of restatement to correct an error. Basis of Presentation and Going Concern Basis of Presentation And Going Concern [Text Block] Document Type Significant Acquisitions and Disposals, Purchase Price Allocation, Number of Assets Number of intangible assets to which purchase price would be allocated The number of intangible assets that the entity acquired in a significant acquisition. Significant Acquisitions and Disposals, Contingent Consideration, Fair Value Fair value of contingent consideration Fair value of potential payments under the contingent consideration arrangement including cash and shares under a significant acquisition or disposal. Schedule of Components of Changes in Derivative Financial Liability [Table Text Block] Schedule of components of changes in the Company's derivative financial instruments liability balance Tabular disclosure of the reconciliation of a concept from the beginning of a period to the end of the period. Black Scholes, Option Pricing Method [Member] Black-Scholes option pricing method Represents the Black-Scholes option pricing method which is used for valuation of derivative instruments. Accounts Receivable, Net, Current Accounts receivable Represents the Binomial option pricing method which is used for valuation of derivative instruments. Binomial, Option Pricing Method [Member] Binomial option pricing method Fair Value of Common Stock, Per Share Estimated fair value of the entity's common stock (in dollars per share) Represents the fair value per share of the entity's common stock. Derivative Financial Instruments Liability [Roll Forward] Changes in the Company's derivative financial instruments liability balance Derivative Financial Instruments Number of Price Protected Units Outstanding Number of Price Protected Units at Issuance Represents the number of price protected units outstanding. Derivative Liabilities for Issued, Units Derivative Liability For Issued Units Represents the accumulated amount of derivative financial instrument liability before any fair value adjustments after issuance. Accumulated Fair Value Changes Represents the accumulated amount of changes in fair value adjustments of derivative liabilities since issuance of derivative financial instrument. Change in Fair Value of Derivative Liability for Previously Outstanding Price Protected Units Derivative Financial Instruments Change in Number of Units Outstanding Represents the change in number of derivative units outstanding during the period. Change in number of price protected units outstanding Derivative liability for changes in issued units during period Represents the value associated with the change in number of derivative units outstanding during the period. Derivative Financial Instruments Change in Units Outstanding, Value Automatic Renewal Period from End of Each Term of Agreement Represents the period by which the term of agreement is automatically renewed at the end of each term of the agreement. Period by which agreement is renewed automatically at the end of each term Bonus as Percentage of Base Salary Represents the bonus as a percentage of the base salary per year based on meeting of certain performance objectives and bonus criteria. Bonus as percentage of base salary Compensation Per Year, Amount Represents the amount of compensation per year. Compensation per year Consulting Agreement to Provide Business Development Services [Member] Represents the consulting agreement entered into by the entity under which an independent management consultant will provide business development services to the entity. Consulting agreement to provide business development services Consulting Agreement to Provide Public Relations and Publicity Services [Member] Represents the consulting agreement entered into by the entity under which an independent management consultant will provide public relations and publicity services to the entity. Consulting agreement to provide public relations and publicity services Non Qualified Stock Options [Member] Represents information pertaining to non-qualified stock options. Non-qualified stock options Severance Payment Equal to Base Compensation in Case of Termination Due to Change in Control Period Represents the period which will be taken into consideration to calculate the base compensation equal to which, severance payment will be paid if the agreement is terminated as a result of a change in control. Period of base compensation received as severance payment if termination occurs due to change in control Severance Payment Equal to Base Compensation in Case of Termination without Cause Period under Condition One Represents the period which will be taken into consideration to calculate the base compensation equal to which, severance payment will be paid if termination without cause occurs within the specified period after the effective date of the agreement. Period of base compensation which would be received as severance payment, if termination occurs within 10 months Severance Payment Equal to Base Compensation in Case of Termination without Cause Period under Condition Two Represents the period which will be taken into consideration to calculate the base compensation equal to which, severance payment will be paid if termination without cause occurs subsequent to the specified period after the effective date of the agreement. Period of base compensation which would be received as severance payment, if termination occurs after 10 months Severance Payment Equal to Base Compensation in Case of Termination without Cause Specified Period after Effective Date Represents the period from the effective date of agreement within which if termination occurs, employee will be eligible for severance payment equal to the base compensation for the specified period. Period within which if termination occurs, employee will be eligible for severance payment equal to 3 months of base compensation Severance Payment Equal to Base Compensation in Case of Termination without Cause Subsequent to Specified Period from Effective Date Represents the period from the effective date of agreement subsequent to which if termination occurs, the employee will be eligible for severance payment equal to the base compensation for the specified period. Period within which if termination occurs, employee will be eligible for severance payment equal to 6 months of base compensation Represents the period after termination due to change in control within which the stock options may be exercised. Exercise period after termination due to change in control Share Based Compensation Arrangements by Share Based Payment Award, Exercisable Period after Termination Due to Change in Control Stock Options with Performance Vesting Criteria [Member] Represents the information pertaining to stock options with performance vesting criteria. Stock options with performance vesting criteria Stock options with time vesting criteria Stock Options with Time Vesting Criteria [Member] Represents the information pertaining to stock options with time vesting criteria. Exercise Price Range .50 to 2.50 [Member] Exercise Price Range .50 to 2.50 Represents stock options in the exercise price range of .50 to 2.50 per share. Exercise Price Range 3.00 to 4.68 [Member] Exercise Price Range 3.00 to 4.68 Represents stock options in the exercise price range of 3.00 to 4.68 per share. Accounts Payable, Current Accounts payable Exercise Price Range 3.00 to 15.00 [Member] Exercise Price Range 3.00 to 15.00 Represents stock options in the exercise price range of 3.00 to 15.00 per share. Contractual Commitment [Table] Discloses the information related to contractual commitments of the entity. Contractual Commitments by Type [Axis] Information by type of contractual commitment. Contractual Commitments by Type [Domain] The list of contractual commitments which the entity has made. Units Issued During Period Number of units issued during the period consisting of common stock and warrants to purchase common stock. Units issued Significant Acquisitions and Disposals Contingent, Consideration Potential Payment Value of potential payments in combination of cash and common stock that may be paid from the contingent consideration arrangement under significant acquisition or disposal. Consideration to be paid in common stock and cash upon the achievement of specific sales and earnings targets Units Exercised by Underwriters Due to Overallotment of Option Exercise of overallotment option by underwriters (in shares) Number of shares of stock exercised by underwriters under an overallotment option during the period. Class of Warrant or Right Number of Warrants Issued Related to Private Placements Warrants issued in connection with private placements (in shares) Represents the number of each class of warrants or rights issued during the reporting period in connection with private placements. Class of Warrant or Right Number of Warrants Issued to Underwriters Warrants issued as compensation to underwriters (in shares) Represents the number of each class of warrants or rights issued during the reporting period as a compensation to underwriters. Class of Warrant or Right Number of Warrants Issued in Public Offering Warrants issued in connection with registered direct public offering (in shares) Represents the number of each class of warrants or rights issued during the reporting period to underwriters in connection with the registered public offering. Class of Warrant or Right Number of Warrants Issued to Related Party Warrants for services provided by a related party (in shares) Represents the number of each class of warrants or rights issued during the reporting period for services provided by a related party. Consulting Agreement to Provide Scientific Consulting Services [Member] Consulting agreement to provide scientific consulting services Represents the consulting agreement entered into by the entity, under which an independent contractor will provide scientific consulting services to the entity. Components of Change [Axis] Information by type of change. Consultant Services Monthly Fee Monthly fee for consultant's services Represents the amount of monthly fee for consultant's services under the consulting agreement. Payment of Committed Service Fees Committed amount paid to MDACC The cash outflow for payment of committed service fees under the agreement. Accrued Liabilities, Current Accrued expenses Additional Paid in Capital Additional paid-in capital Additional Paid-In Capital Additional Paid-in Capital [Member] Adjustments for Error Correction [Domain] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Costs associated with recapitalization Issuance of 15,779, 20,205 and 20,610 warrants to selling agents for the year 2007, 2006 and 2005, respectively Adjustments to Additional Paid in Capital, Warrant Issued Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock based compensation Allocated Share-based Compensation Expense Total Amortization of deferred debt costs and original issue discount Amortization of Debt Discount (Premium) Amortization of deferred debt costs and original issue discount Amortization of Financing Costs and Discounts Outstanding stock options and other common stock equivalents excluded from the calculation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares used in calculation of basic and diluted net loss per common share excluded as antidilutive share equivalents Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss Per Share Antidilutive Securities, Name [Domain] Antidilutive Securities [Axis] Current assets: Assets, Current [Abstract] Assets Assets [Abstract] Assets, Current Total current assets Assets Total assets Asset Purchase Agreement Asset Purchase Agreement Business Combination Disclosure [Text Block] Cash in bank Cash Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents-End of period Cash and cash equivalents-Beginning of period Change in fair value of warrants during the period Change During Period, Fair Value Disclosure [Member] Balance of warrants outstanding at the beginning of the period Balance of warrants outstanding at the end of the period Class of Warrant or Right, Outstanding Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants (in dollars per share) Weighted average exercise price (in dollars per share) Class of Stock [Domain] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of common shares that can be purchased upon exercise of warrant Number of shares that can be purchased from exercise of warrants Licensing Agreements Collaborative Arrangement Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies Commitments and Contingencies. Commitments and contingencies (Note 8) Common Stock Common Stock [Member] Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Value, Issued Common stock, $0.0001 par value, 150,000,000 and 100,000,000 shares authorized at September 30, 2012 and December 31, 2011, respectively; 14,180,726 and 10,737,026 issued and outstanding at September 30, 2012 and December 31, 2011, respectively Common Stock, Shares, Issued Common stock, shares issued Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Convertible Preferred Stock Converted to Other Securities Conversion of Series A preferred stock and issuance of common stock Convertible Debt, Current Convertible debentures Costs and expenses: Costs and Expenses [Abstract] Costs and Expenses Total operating expenses Debt Conversion, Original Debt, Amount Conversion of $2,335,050 of 6% debentures (in dollars) Interest rate, convertible debenture (as a percent) Debt Instrument, Interest Rate, Stated Percentage Deferred Stock Based Compensation Deferred Compensation, Share-based Payments [Member] Depreciation and amortization Depreciation, Depletion and Amortization Derivative financial instruments Derivative [Line Items] Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative [Table] Derivative Financial Instruments Derivative Liabilities, Noncurrent Derivative financial instruments Derivative liabilities related to Warrants Balance of derivative financial instruments liability at the beginning of the period Balance of derivative financial instruments liability at the end of the period Derivative, by Nature [Axis] Derivative, Name [Domain] Accounting for Share-Based Payments Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Accounting for Share-Based Payments Dividends, Preferred Stock Preferred stock dividend NET LOSS PER COMMON SHARE-BASIC AND DILUTED: Earnings Per Share, Basic and Diluted [Abstract] Net loss (in dollars per share) Earnings Per Share, Basic and Diluted Earnings Per Share [Text Block] Net Loss Per Share Net Loss Per Share Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Weighted-average remaining vesting period for recognition Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Stock-based compensation expense Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options Unrecognized compensation cost Equity Issuance, Per Share Amount Offer price per unit (in dollars per share) Purchase price paid by investor for each unit (in dollars per share) Equity Component [Domain] Adjustments for Error Corrections [Axis] Balance at the end of the period Estimate of Fair Value, Fair Value Disclosure [Member] Executive Compensation Contracts [Member] Executive agreement with Steve Zaniboni Measurement Frequency [Axis] Expected volatility (as a percent) Fair Value Assumptions, Expected Volatility Rate Fair Value, Hierarchy [Axis] Liability Class [Axis] Recurring basis Fair Value, Measurements, Recurring [Member] Balance at the beginning of the period Balance at the end of the period Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair Value, Measurement Frequency [Domain] Risk-free interest rate (as a percent) Fair Value Assumptions, Risk Free Interest Rate Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value by Liability Class [Domain] Expected warrant term Fair Value Assumptions, Expected Term Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract] Range of assumptions used to determine the fair value of warrants Fair value of New Warrants Issued During the Period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issues Schedule of assumptions used to determine the fair value of the warrants Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block] Fair value measurements Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Dividend yield (as a percent) Fair Value Assumptions, Expected Dividend Rate Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Schedule of the Company's liabilities that are measured and recognized at fair value on a recurring basis classified under the appropriate level of the fair value hierarchy Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Unrealized gains or (losses) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Reconciliation of the beginning and ending balances Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Schedule of changes in the fair value of the Company's Level 3 liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Gains (Losses) on Extinguishment of Debt Gain on extinguishment of debt Gain on extinguishment of debt General and administrative General and Administrative Expense General and Administrative Expense [Member] Included in general and administrative expense Consolidated Statements of Operations and Comprehensive (Loss) Income Income Tax Disclosure [Text Block] Income Taxes Income Taxes Income Taxes Paid Cash paid for taxes Increase (Decrease) in Accounts Receivable Decrease (increase) in accounts receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities (Decrease) increase in accounts payable, accrued expenses and other Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Other Operating Assets Decrease (increase) in other assets Increase (Decrease) in Prepaid Expense (Increase) decrease in prepaid expenses Increase (Decrease) in Security Deposits (Increase) in security deposits Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Interest payable Interest Payable, Current Interest expense Interest Expense Cash paid for interest Interest Paid Interest income Investment Income, Net Liabilities, Current Total current liabilities Current liabilities: Liabilities, Current [Abstract] Liabilities Total liabilities Liabilities and Stockholders' Equity (Deficiency) Liabilities and Equity [Abstract] Liabilities and Equity Total liabilities and stockholders' equity (deficiency) License and Services Revenue License fees One time license fee due upon execution of the agreement Licensing Agreements [Member] Collaboration and License Agreements Loss Contingencies [Table] Loss Contingency Nature [Axis] Commitments and Contingencies Loss Contingencies [Line Items] Loss Contingency, Nature [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash used in operating activities Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net change in cash and equivalent Net Cash Provided by (Used in) Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Income (Loss) Available to Common Stockholders, Basic Net loss and comprehensive loss attributable to common stockholders Net losses attributable to common stockholders Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Net (loss) income and comprehensive (loss) income Net loss Net Income (Loss) Attributable to Parent Cumulative effect of early adopting ASC Topic 815-40 New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income Noncash Investing and Financing Items [Abstract] Supplemental disclosure of non-cash investing and financing activities: Nonoperating Income (Expense) [Abstract] Other income (expense): Operating Income (Loss) Loss from operations Condensed Consolidated Financial Statements Condensed Consolidated Financial Statements Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other Assets, Noncurrent Other assets Interest expense on convertible debentures paid in stock Paid-in-Kind Interest Payments of Debt Issuance Costs Debt issuance costs Redemption of common stock Payments for Repurchase of Common Stock Payment of finders' fee on preferred stock Payments of Stock Issuance Costs Payments to Acquire Property, Plant, and Equipment Capital expenditures Payment of preferred stock dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Assets acquired in Etherogen, Inc. merger Payments to Acquire Businesses, Net of Cash Acquired Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 20,000,000 shares authorized, 95,600 shares outstanding at September 30, 2012 and December 31, 2011, designated as Series A Convertible Preferred Stock with liquidation preference of $956,000 at September 30, 2012 and December 31, 2011 Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Accretion of Redemption Discount Accretion of preferred stock dividends (restated) Preferred Stock Dividends and Other Adjustments [Abstract] Items attributed to preferred stock: Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred stock dividend Preferred Stock Dividends, Income Statement Impact Series A Convertible Preferred Stock, liquidation preference (in dollars) Preferred Stock, Liquidation Preference, Value Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock Preferred Stock [Member] Prepaid expenses Prepaid Expense and Other Assets, Current Private Placement [Member] Private placement financings Proceeds from sale of 6% convertible debenture Proceeds from Convertible Debt Proceeds from Warrant Exercises Proceeds from the exercise of warrants Proceeds from (Repayments of) Short-term Debt Note (repayment) Proceeds from Issuance of Common Stock Proceeds from sale of common stock, net of expenses Net proceeds from offering Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from sale of preferred stock Property and Equipment Property, Plant and Equipment, Net Property and equipment, net Property, Plant and Equipment Disclosure [Text Block] Property and Equipment Correction of error Quantifying Misstatement in Current Year Financial Statements, Amount Range [Axis] Range [Domain] Related Party Transactions Disclosure [Text Block] Related Party Transactions Related Party Transactions Research and Development Arrangement [Member] Research Agreement Research and development Research and Development Expense (Excluding Acquired in Process Cost) Research and Development Expense [Member] Included in research and development expense Research and Development in Process Purchased in process research and development expense-related party Purchased in process research and development Correction of error Restatement Adjustment [Member] Restricted common stock Restricted Stock [Member] Retained Earnings (Accumulated Deficit) Deficit accumulated during development stage Deficit Accumulated During Development Stage Retained Earnings [Member] Revenue Recognition, Milestone Method, Revenue Recognized Milestone fees Milestone payment received Royalty Revenue Royalty income Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term Total revenues Revenue, Net Scenario, Unspecified [Domain] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of stock option activity and of changes in stock options outstanding under the Plan Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions Schedule of shares used in calculation of basic and diluted net loss per common share excluded as antidilutive share equivalents Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of stock-based compensation expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Significant Acquisitions and Disposals [Table] Security Deposit Deposits Stock based compensation expense Share-based Compensation Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Weighted Average Exercise Price Per Share Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted (in shares) Grant of non-qualified vested stock option to purchase number of shares of common stock Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock Options Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Exercise price (in dollars per share) Issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average fair value per share estimated as of the grant date Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Intrinsic Value Weighted-average fair value per share of all options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Weighted-average assumptions Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Forfeited (in shares) Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance outstanding at the beginning of the period (in dollars per share) Balance outstanding at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding Exercise price, low end of the range (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Balance outstanding at the beginning of the period (in shares) Balance outstanding at the end of the period (in shares) Award Type [Domain] Exercise price, upper end of the range limit (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Balance (in shares) Balance (in shares) Shares, Issued Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Asset Purchase Agreement Significant Acquisitions and Disposals [Line Items] Statement [Table] Scenario [Axis] Statement Statement [Line Items] Stockholders' Equity Consolidated Statements of Stockholders' Equity (Deficiency) Consolidated Statements of Cash Flows Consolidated Statements of Cash Flows (Parenthetical) Equity Components [Axis] CONSOLIDATED BALANCE SHEETS Class of Stock [Axis] Stock Issued During Period, Value, Conversion of Units Etherogen Inc. conversion units-8/06/10 Stock Issued During Period, Shares, Period Increase (Decrease) Stock Issued During Period, Shares, Issued for Services Common stock issued for services (in shares) Stock Repurchased and Retired During Period, Value Retirement of treasury shares Stock Redeemed or Called During Period, Shares Redemption of shares held by Panetta Partners, Inc. (in shares) Stock Issued During Period, Shares, Conversion of Units Etherogen Inc. conversion units-8/06/10 (in shares) Stock Issued During Period, Shares, Acquisitions Common stock issued in connection with an asset purchase agreement (in shares) Shares issued in connection with Asset Purchase Agreement with MultiGen Diagnostics, Inc & Plan of Merger with Etherogen, Inc. (in shares) Issuance of shares of common stock pursuant to Asset Purchase Agreement with Multigen Diagnostics, Inc. & Plan of Merger with Etherogen, Inc. Stock Options [Member] Stock options Options Shares issued in connection with Asset Purchase Agreement with MultiGen Diagnostics, Inc & Plan of Merger with Etherogen, Inc. Stock Issued During Period, Value, Acquisitions Total purchase consideration paid in common stock Issuance of common stock for cash at $0.003 per share for the year 2002 Stock Issued During Period, Value, New Issues Redemption of shares held by Panetta Partners, Inc. Stock Redeemed or Called During Period, Value Stock Issued During Period, Value, Issued for Services Common stock issued for services Stock Issued During Period, Shares, Other Issuance of common stock to shareholder as finder's fees (in shares) Conversion of $2,335,050 of 6% debentures Stock Issued During Period, Value, Conversion of Convertible Securities Stock Repurchased and Retired During Period, Shares Retirement of treasury shares (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Shares issued in connection with Board Compensation (in shares) Issuance of 137,739 shares of common stock Stock Issued Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Shares issued in connection with Board Compensation Stock Issued During Period, Shares, New Issues Issuance shares of common stock Issuance of common stock for cash at $0.003 per share for the year 2002 (in shares) Common stock issued in connection with an asset purchase agreement (in shares) Issuance of common stock to shareholder as finder's fees Stock Issued During Period, Value, Other Stockholders' equity (deficiency) Stockholders' Equity Attributable to Parent [Abstract] Balance Balance Stockholders' Equity Attributable to Parent Total stockholders' equity (deficiency) Stockholders' Equity (Deficiency) Stockholders' Equity (Deficiency) Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity, Period Increase (Decrease) Subsequent Events Subsequent Events [Text Block] Subsequent Events Subsequent Event Type [Domain] Subsequent Events Subsequent Event [Line Items] Subsequent Event Type [Axis] Subsequent Event [Table] Subsequent Event Subsequent Event [Member] Supplemental Cash Flow Information [Abstract] Supplementary disclosure of cash flow activity: Treasury Stock, Shares, Acquired Issuance of treasury shares (in shares) Treasury Shares Treasury Stock [Member] Issuance of treasury shares Treasury Stock, Value, Acquired, Cost Method Change in fair value of derivative instruments-warrants Unrealized Gain (Loss) on Derivatives Change in fair value of financial instruments Change in fair value of warrants during the period Valuation Technique [Axis] Valuation Technique [Domain] Warrants Warrant [Member] Warrants and Rights Note Disclosure [Abstract] Warrants Weighted average shares of common stock outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding: (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Amount committed to be paid to MDACC Purchase Obligation Share Based Compensation Arrangement by Share Based Payment Award Options Annual Grant Number of shares available for purchase under an annual grant. Number of shares available for purchase under an annual grant Etherogen Inc [Member] Etherogen, Inc Represents information that pertains to Etherogen, Inc. Agreement With Ipsogen SA [Member] Ipsogen S.A. Represents information pertaining to the agreement entered into with Ipsogen S.A. in 2007.